Synjardy XR 5 mg/1 (Empagliflozin, Metformin Hydrochloride TABLET, EXTENDED RELEASE) 5 mg/1

Synjardy XR 5 mg/1 is an extended-release tablet combining empagliflozin and metformin hydrochloride. It is designed to help manage blood sugar levels in adults with type 2 diabetes. This medication is suitable for those who need dual therapy to control their condition.

Strength

5 mg/1

Pack Size

180 TABLET, EXTENDED RELEASE in 1 BOTTLE (0597-0290-59)

Manufacturer / TM Owner

Boehringer Ingelheim Pharmaceuticals, Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Synjardy XR 5 mg/1 is primarily used to improve glycemic control in adults with type 2 diabetes. It works by combining two active ingredients: empagliflozin, which helps the kidneys remove excess glucose from the body, and metformin hydrochloride, which reduces the amount of sugar released by the liver and improves the body's response to insulin. This combination therapy is often prescribed when diet and exercise alone are not enough to manage blood sugar levels effectively.

Side Effects

Common effects of Synjardy XR 5 mg/1 may include symptoms such as nausea, diarrhea, and headache. Some individuals might experience urinary tract infections or low blood sugar levels, especially when starting the medication or adjusting the dose. It is important to monitor for any unusual symptoms and consult a healthcare provider if they persist or worsen.

Precautions & Warnings

Synjardy XR 5 mg/1 should be taken exactly as prescribed. It is important to stay hydrated and maintain a balanced diet while using this medication. Patients with kidney problems or a history of lactic acidosis should discuss their medical history with a healthcare provider before starting this treatment. Always follow the advice of a healthcare professional regarding the use of this medication.

Avoid Interactions

Synjardy XR 5 mg/1 may interact with certain medications, including diuretics, blood pressure medications, and other drugs that affect kidney function. Alcohol can increase the risk of lactic acidosis, so it is advisable to limit alcohol consumption while taking this medication. Always inform your healthcare provider about all the medications you are taking to avoid potential interactions.

Frequently Asked Questions

Synjardy XR 5 mg/1 is used to improve glycemic control in adults with type 2 diabetes. It combines empagliflozin and metformin hydrochloride to help manage blood sugar levels.

Synjardy XR 5 mg/1 should be taken orally, usually once daily with a meal, as prescribed by a healthcare provider. It is important to follow the dosage instructions carefully.

Common side effects may include nausea, diarrhea, headache, and urinary tract infections. Some individuals might experience low blood sugar levels.

Synjardy XR 5 mg/1 may interact with certain medications, so it is important to inform your healthcare provider about all the drugs you are taking.

Synjardy XR 5 mg/1 is designed for adults with type 2 diabetes who need dual therapy. It is not suitable for everyone, and individual suitability should be assessed by a healthcare provider.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.